<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>One hundred and forty-five patients with <z:hpo ids='HP_0004757'>paroxysmal atrial fibrillation</z:hpo> were examined to evaluate the effectiveness of the correction of physical state in the course of complex (somatotropic and psychotropic) therapy </plain></SENT>
<SENT sid="1" pm="."><plain>Personality characteristics of patients with <z:hpo ids='HP_0011675'>arrhythmias</z:hpo>, the structure and severity of stress and <z:hpo ids='HP_0000739'>anxiety</z:hpo>-<z:e sem="disease" ids="C0868892,C0868894,C0011581,C0012706,C0868893" disease_type="Mental or Behavioral Dysfunction" abbrv="">depressive disorders</z:e> preceding the manifestation of <z:hpo ids='HP_0004757'>paroxysmal atrial fibrillation</z:hpo> were studied </plain></SENT>
<SENT sid="2" pm="."><plain>Patients were examined at baseline and at the 21st day of therapy using clinical and instrumental methods (Holter ECG monitoring) and psychometric scales (the Beck <z:hpo ids='HP_0000716'>Depression</z:hpo> Inventory, the Zung Self-Rating <z:hpo ids='HP_0000739'>Anxiety</z:hpo> Scale, the Hamilton <z:hpo ids='HP_0000716'>Depression</z:hpo> Rating scale, the Hamilton <z:hpo ids='HP_0000739'>Anxiety</z:hpo> Rating scale) </plain></SENT>
<SENT sid="3" pm="."><plain>The complex treatment of patients with <z:hpo ids='HP_0004757'>paroxysmal atrial fibrillation</z:hpo> with SSRI antidepressants (<z:chebi fb="0" ids="7936">paroxetine</z:chebi>, <z:chebi fb="0" ids="5138">fluvoxamine</z:chebi>, <z:chebi fb="0" ids="9123">sertraline</z:chebi>) allowed to rapidly reduce neurotic <z:hpo ids='HP_0000739'>anxiety</z:hpo> <z:e sem="disease" ids="C0868892,C0868894,C0011581,C0012706,C0868893" disease_type="Mental or Behavioral Dysfunction" abbrv="">depressive disorders</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>There was a significant positive trend in the course and frequency of paroxysms of <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> on 21st day of treatment </plain></SENT>
<SENT sid="5" pm="."><plain>These remedies help to reduce the duration of <z:hpo ids='HP_0011675'>arrhythmia</z:hpo>'s attack which has already begun facilitating its relief </plain></SENT>
<SENT sid="6" pm="."><plain>After 3-5 months of such regular complex pharmacotherapy, paroxysms of <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> were completely stopped in 10.3% of patients </plain></SENT>
<SENT sid="7" pm="."><plain>The follow-up investigation 18 months later showed that patients with certain personality traits and the positive dynamics of <z:hpo ids='HP_0004757'>paroxysmal atrial fibrillation</z:hpo> under a complex (somatotropic and psychotropic) treatment can develop <z:e sem="disease" ids="C1391991" disease_type="Mental or Behavioral Dysfunction" abbrv="">cardiophobia</z:e>' attacks in recurrent significant stress situations </plain></SENT>
<SENT sid="8" pm="."><plain>Side-effects of the drugs were not significant and did not require discontinuation of the treatment </plain></SENT>
</text></document>